The 1246G→A polymorphism of the HCRTR2 gene is not associated with migraine

Cephalalgia

Volumn 27, Issue 8, 2007, Pages 945-949

  Pinessi, L ^a   Binello, E ^a   De Martino, P ^a   Gallone, S ^a   Gentile, S ^a   Rainero, I ^a   Rivoiro, C ^a   Rubino, E ^a   Savi, L ^a   Valfre W ^a   Vaula, G ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Hypocretin receptor 2 gene; Migraine; Migraine with aura; Migraine without aura; Polymorphism

Indexed keywords

OREXIN 2 RECEPTOR; G PROTEIN COUPLED RECEPTOR; NEUROPEPTIDE RECEPTOR; OREXIN RECEPTORS; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; RISK FACTOR; STATISTICAL SIGNIFICANCE; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIGRAINE DISORDERS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NEUROPEPTIDE;

EID: 34547194664     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2007.01347.x     Document Type: Article

References (30)

1. Lipton RB, Scher AI, Kolodner K, Liberman J, Steiner TJ, Stewart WF. Migraine in the United States: epidemiology and patterns of health care use. Neurology 2002 58 : 885 94.
2. Ophoff RA, Terwindt GM, Vergouwe MN, van Eijk R, Oefner PJ, Hoffman SM et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 1996 87 : 543 52.
3. De Fusco M, Marconi R, Silvestri L, Atorino L, Rampolli L, Morgante L et al. Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2. Nat Genet 2003 23 : 192 6.
4. Dichgans M, Freilinger T, Eckstein G, Babini E, Lorenz-Depiereux B, Biskup S et al. Mutation in the neuronal voltage-gated sodium-channel SCN1A in familial hemiplegic migraine. Lancet 2005 366 : 371 7.
5. De Lecea L, Kilduff TS, Peyron C, Gao X, Foye PE, Danielson PE et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci USA 1998 95 : 322 7.
6. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behaviour. Cell 1998 92 : 573 85.
7. Ferguson AV, Samson WK. The orexin/hypocretin system: a critical regulator of neuroendocrine and autonomic function. Front Neuroendocrinol 2003 24 : 141 50.
8. Sakurai T. Roles of orexin/hypocretin in regulation of sleep/wakefulness and energy homeostasis. Sleep Med Rev 2005 9 : 231 41.
9. Xia JX, Chen XW, Cheng SY, Hu ZA. Mechanisms of orexin A-evoked changes of intracellular calcium in primary cultured cortical neurons. Neuroreport 2005 16 : 783 6.
10. Smart D, Jerman JC. The physiology and pharmacology of the orexins. Pharmacol Ther 2002 94 : 51 61.
11. Borgland SL, Taha SA, Sarti F, Fields HL, Bonci A. Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine. Neuron 2006 49 : 589 601.
12. Harris GC, Wimmer M, Aston-Jones G. A role for lateral hypothalamic orexin neurons in reward seeking. Nature 2005 437 : 556 9.
13. Overeem S, van Vliet JA, Lammers GJ, Zitman FG, Swaab DF, Ferrari MD. The hypothalamus in episodic brain disorders. Lancet Neurol 2002 1 : 437 44.
14. Bingham S, Davey PT, Babbs AJ, Irving EA, Sammons MJ, Wyles M et al. Orexin-A, an hypothalamic peptide with analgesic properties. Pain 2001 92 : 81 90.
15. Yamamoto Y, Saito O, Shono K, Aoe T, Chiba T. Anti-mechanical allodynic effect of intrathecal and intracerebroventricular injection of orexin-A in the rat neuropathic pain model. Neurosci Lett 2003 347 : 183 6.
16. Holland PR, Akerman S, Goadsby PJ. Orexin 1 receptor activation attenuates neurogenic dural vasodilation in an animal model of trigeminovascular nociception. J Pharmacol Exp Ther 2005 315 : 1380 5.
17. Rainero I, Gallone S, Valfrè W, Ferrero M, Angilella G, Rivoiro C et al. A polymorphism of the hypocretin receptor 2 gene is associated with cluster headache. Neurology 2004 63 : 1286 8.
18. Schurks M, Kurth T, Geissler I, Tessmann G, Diener HC, Rosskopf D. Cluster headache is associated with the G1246A polymorphism in the hypocretin receptor 2 gene. Neurology 2006 66 : 1917 9.
19. D'Amico D, Centonze V, Grazzi L, Leone M, Ricchetti G, Bussone G. Coexistence of migraine and cluster headache: report of 10 cases and possible pathogenetic implications. Headache 1997 37 : 21 5.
20. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders, 2nd Edition. Cephalalgia 2004 24 (Suppl. 1 1 151.
21. Rainero I, Pinessi L, Salani G, Valfrè W, Rivoiro C, Savi L, et al. A polymorphism in the interleukin-1alpha gene influences the clinical features of migraine. Headache 2002 42 : 337 40.
22. Rainero I, Salani G, Valfré W, Savi L, Rivoiro C, Ferrero M et al. Absence of linkage between the interleukin-6 gene (-174 G/C) polymorphism and migraine. Neurosci Lett 2003 343 : 155 8.
23. Rainero I, Grimaldi LM, Salani G, Valfrè W, Rivoiro C, Savi L, Pinessi L. Association between the tumor necrosis factor-alpha -308 G/A gene polymorphism and migraine. Neurology 2004 62 : 141 3.
24. Rainero I, Dall'Omo AM, Rubino E, Valfrè W, Fasano ME, Rivoiro C et al. HLA-DRB1 genotyping in Italian migraine patients. Neurosci Lett 2006 393 : 90 9.
25. Bird TD, Jarvik GP, Wood NW. Genetic association studies: genes in search of diseases. Neurology 2001 57 : 1153 4.
26. Baumber L, Sjostrand C, Leone M, Harty H, Bussone G, Hillert J et al. A genome-wide scan and HCRTR2 candidate gene analysis in a European cluster headache cohort. Neurology 2006 66 : 1888 93.
27. Peyron C, Tighe DK, van den Pol AN, de Lecea L, Heller HC, Sutcliffe JG, Kilduff CS. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 1998 18 : 9996 10015.
28. Walling SG, Nutt DJ, Lalies MD, Harley CW. Orexin-A infusion in the locus ceruleus triggers norepinephrine (NE) release and NE-induced long-term potentiation in the dentate gyrus. J Neurosci 2004 24 : 7421 6.
29. Burdakov D, Liss B, Ashcroft FM. Orexin excites GABAergic neurons of the arcuate nucleus by activating the sodium-calcium exchanger. J Neurosci 2003 23 : 4951 7.
30. Korotkova TM, Sergeeva OA, Eriksson KS, Haas HL, Brown RE. Excitation of ventral tegmental area dopaminergic and nondopaminergic neurons by orexins/hypocretins. J Neurosci 2003 23 : 7 11.